雷米普利与白藜芦醇联用通过减弱RhoA/ROCK通路改善早期糖尿病肾病大鼠肾小球硬化实验研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:

广东省中医药局项目(20202265)


Experiment Study of Ramipril Combined with Resveratrol Improves Glomerulosclero⁃ sis in Early Diabetic Kidney Disease Rats by Weakening RhoA/ROCK Pathway
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨雷米普利与白藜芦醇联用对糖尿病肾病(DKD)大鼠早期肾小球硬化的干预作用。方 法:选用 Sprague-Dawley(SD)大鼠进行实验,其中对照组 8 只、腹腔注射链脲佐菌素(STZ)诱导构建早期 DKD 模型组 32 只。建模成功后,对照组大鼠每天给予 1 mL 磷酸盐缓冲液(PBS)灌胃,STZ 诱导糖尿病大鼠 再分为以下 4 组:第 1 组,每天给予 1 mL PBS 灌胃;第 2 组,每天给予白藜芦醇 15 mg/kg;第 3 组,每天给 予雷米普利 10 mg/kg;第 4 组,每天给予白藜芦醇(15 mg/kg)和雷米普利(10 mg/kg),连续治疗 10 d。所有 大鼠均使用 5%异氟烷麻醉情况下进行心脏采血后处死,并采集组织标本进一步分析。结果:STZ 诱导的 DKD 大鼠(第 1 组)出现早期症状:微量蛋白尿和肾小球硬化/肾小球比值升高(P<0.05)。第 2 组肾小球硬化/肾 小球比值没有明显降低,第 3 组和第 4 组中肾小球硬化/肾小球比值降低(P<0.05)。介导组织发生纤维化的 TGF-β 信号通路相关蛋白在各组间的肾脏中表达无差异。但 STZ 诱导的 DKD 组肾脏 RhoA 和 ROCK2 蛋白水 平升高,经过雷米普利治疗或雷米普利与白藜芦醇联用治疗的情况下 RhoA 和 ROCK2 蛋白表达量则显著下降 至接近对照组水平。结论:DKD 早期的大鼠肾小球硬化主要是通过 RhoA/ROCK2 信号通路介导。使用雷米普 利或雷米普利与白藜芦醇联用治疗可有效降低 RhoA 与 ROCK 蛋白表达水平,减轻肾脏纤维化,并揭示此病程 阶段的肾小球硬化是可逆的。

    Abstract:

    Abstract:Objective:To investigate the intervention effect of Ramipril combined with resveratrol on early glomerulosclerosis in diabetic kidney disease (DKD) rats. Methods:Sprague-Dawley (SD) rats were selected for the experiment, with 8 in the control group and 32 in the intraperitoneal injection of streptozotocin (STZ) to induce the construction of early DKD models. After successful modeling,rats in the control group were given 1 mL of phosphate buffer solution (PBS) by gavage every day. Rats with STZ- induced diabetes were divided into the following four groups:Group 1,1 mL PBS was given by gavage every day. Group 2,received 15 mg/kg of resveratrol daily. Group 3,given 10 mg/kg of Ramipril daily. Group 4 was treated with resveratrol (15 mg/kg) and Ramipril (10 mg/kg) daily for 10 consecutive days. All rats were anesthetized with 5% isoflurane for cardiac blood collection and euthanized,and tissue samples were collected for further analysis. Results:STZ-induced DKD rats (group 1) showed early symptoms of microalbuminuria and increased glomerulosclerosis/glomerular ratio (P<0.05). The glomerulosclerosis/ glomerular ratio did not significantly decrease in the second group,while the glomerulosclerosis/glomerular ratio decreased in the third and fourth groups (P<0.05). There was no difference in the expression of TGF-β signaling pathway related proteins with mediating tissue fibrosis in the kidneys between groups. However, in the STZ-induced DKD group,the levels of RhoA and ROCK2 proteins in the kidneys were increased. After treatment with Ramipril or the combination of Ramipril and resveratrol,the expression levels of RhoA and ROCK2 proteins were significantly decreased to levels close to the control group. Conclusion:Early glomerulosclerosis in rats with DKD is mainly mediated through the RhoA/ROCK2 signaling pathway. The use of Ramipril or the combination of Ramipril and resveratrol for treatment can effectively reduce the expression levels of RhoA and ROCK proteins,alleviate renal fibrosis,and reveal that glomerulosclerosis at this stage of the disease is reversible.

    参考文献
    相似文献
    引证文献
引用本文

林添辉,崔艳铭,吴传聪,卢勤燕,魏建波,丁韦仁,李业豪,彭翔.雷米普利与白藜芦醇联用通过减弱RhoA/ROCK通路改善早期糖尿病肾病大鼠肾小球硬化实验研究[J].新中医,2023,55(14):1-7

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-24
  • 出版日期: